Alaunos Therapeutics, Inc. (TCRT) Insider Trading -- Recent Executive & Director Transactions

5 insiders reported 17 Form 4 transactions for Alaunos Therapeutics, Inc. (TCRT) over the past 18 months (most recent 2026-07-02). Recent activity: Weis Holger (Chief Executive Officer) Buy 3,880 shares, Weis Holger (Chief Executive Officer) Buy 7,761 shares, Postma Robert W (Director) Buy 6,274 shares, Vieser Jaime (Director) Buy 6,515 shares, Jerman Michael Allen (Director) Buy 6,032 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-07-02Weis HolgerChief Executive OfficerBuy3,880$8,769
2026-06-17Weis HolgerChief Executive OfficerBuy7,761$17,540
2026-05-01Postma Robert WDirectorBuy6,274$16,250
2026-05-01Vieser JaimeDirectorBuy6,515$16,874
2026-05-01Jerman Michael AllenDirectorBuy6,032$15,623
2026-01-15Postma Robert WDirectorBuy5,622$16,248
2026-01-15Vieser JaimeDirectorBuy5,839$16,875
2026-01-15Jerman Michael AllenDirectorBuy5,406$15,623
2025-11-26Jerman Michael AllenDirectorBuy4,183$13,218
2025-11-26Vieser JaimeDirectorBuy5,340$16,874
2025-11-26Postma Robert WDirectorBuy5,142$16,249
2025-08-20Groenewald FerdinandVice President of FinanceBuy10,775$0
2025-07-07Postma Robert WDirectorBuy4,050$0
2025-07-07Vieser JaimeDirectorBuy3,400$0
2025-06-26Postma Robert WDirectorBuy20,804$60,748
2025-04-15Postma Robert WDirectorBuy20,804$60,748
2025-04-15Vieser JaimeDirectorBuy17,465$0

Source: SEC Form 4 filings · as of 2026-07-02